Narrative Review

Page 2

Recently published articles about Narrative Review

PCC
Tech Gaming Designs, Neurodevelopmental Vulnerabilities, and Internet Gaming Disorder Risk
Narrative Review

July 23, 2024

The authors review the relevant research in the field of internet gaming disorder and provide an approach to identification and management.
, ,
JCP
Immune Targeted Therapies for Depression: Antidepressant Effects of Monoclonal Antibodies
Narrative Review

June 24, 2024

Immune dysregulation may contribute to treatment resistance in depression. Monoclonal antibodies have shown promise in treating depression when used for inflammatory disorders and may offer new hope for patients...
, , , et al
PCC
Alternative Treatment for Agitation in Schizophrenia and Bipolar Disorder
Narrative Review

January 30, 2024

While oral and intramuscular formulations of pharmacologic agents continue to be commonly used to treat acute agitation, novel agents with alternative routes of delivery are becoming available.
, , , et al
PCC
Neuropsychiatric Manifestations and Management of Tuberous Sclerosis
Narrative Review

January 4, 2024

Ninety percent of individuals with tuberous sclerosis have associated neuropsychiatric manifestations including ADHD, autism spectrum disorder, and intellectual disability, which are typically underidentified and undertreated.
, ,
PCC
Fentanyl-Contaminated Oxycodone
Narrative Review

November 9, 2023

The growing use of fentanyl-contaminated products is fueling the US opioid crisis. This study reviewed the rising prevalence of nonprescription fentanyl in counterfeit oxycodone, paying specific attention to oxycodone...
,
PCC
Xylazine as a Fentanyl Adulterant in the US
Narrative Review

October 31, 2023

Data obtained from studies between 2006 and 2022 indicate a rapidly increasing incidence of xylazine overdose in the United States, with overdose cases now being seen in 25 states.
,
PCC
Eating Disorders and Reproductive Health
Narrative Review

August 31, 2023

Recognition and treatment of eating disorders in women prior to conception can minimize obstetric risks to the woman and potential long-term adverse effects on the offspring.
,
PCC
Wernicke’s Encephalopathy in Patients With Psychiatric History
Narrative Review

July 20, 2023

Wernicke’s encephalopathy can present concomitantly with psychiatric decompensation, often requiring treatment with both neuroleptics and thiamine.
, , , et al
PCC
L-Methylfolate as Adjunctive Therapy in MDD Treatment
Narrative Review

May 9, 2023

l-Methylfolate is effective as an adjunctive treatment in MDD and may especially benefit patients with higher body mass index and inflammation.
, ,
l-Methylfolate as Adjunctive Therapy in the Treatment of Major Depressive Disorder">
PCC
Collaborative Care Model Education Opportunities
Narrative Review

April 25, 2023

The Collaborative Care Model (CoCM) is an evidence-based methodology to improve access to mental health care, but studies on how CoCM is taught are sparse. Future opportunities abound to...
, , , et al
JCP
Repurposing Psychiatric Drugs
Narrative Review

March 20, 2023

Drugs labeled as “psychotropic” often have widespread reach and impact throughout the brain and body. Thus, many of these drugs could be repurposed for non-psychiatric indications of high public...
, , , et al
PCC
Management of Psychiatric Conditions in POTS
Narrative Review

January 31, 2023

This review provides an evidence-based approach to treating common psychiatric conditions in those who suffer from POTS, with a particular emphasis on side effects that may worsen the associated...
, , , et al

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe